Do you want to read an article? Please log in or register.
Ultra-Low-Dose Inhalation of Melphalan as an Additional Treatment for COVID-19-Associated Pneumonia
Pneumonia
COMMENTED
Related content
Asthma
Impact of the COVID-19 Pandemic on Lung Function and Treatment Decisions in Children with Asthma: A Retrospective Study
J Clin Med
Abdul-Razzak J, Ionescu M, Diaconu R, Popescu AD, Niculescu EC, Petrescu IO, Singer CE, Coșoveanu CS, Anghelina L, Gheonea C
doi: 10.3390/jcm14103289
RECOMMENDED
Asthma
Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometasone furoate dry powder inhaler in Indian asthma patients
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Patel C, Sheth V, Koppula R, Kumar A, Bhate AS, Sahoo D, Jain MK, Mondal A, Parmar D, Kansagra K, Shrivastava R, Pathak H
doi: 10.1016/j.rmed.2025.108293
Cough
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension
Am J Respir Crit Care Med
Hill NS, Gillies H, Chakinala MM, Feldman JP, Hoeper MM, Jing ZC, McLaughlin VV, Rosenkranz S, Escribano-Subias P, Ghio S, Gomberg-Maitland M, Habib N, Kopec G, Langleben D, Lescano A, Ramirez A, Rischard F, Sitbon O, Skride A, Dake BT, Khindri S, Langley J, Niven R, Zhang X, Humbert M, IMPAHCT Investigators
doi: 10.1093/ajrccm/aamaf128
Pneumonia
Determinants of Ultra-Early Aspiration Pneumonia in Acute Intracerebral Hemorrhage Presenting to the Emergency Department
J Clin Med
Ceccarelli G, Bortolani L, Branda F, Albanese M, Cedrone MC, Baratta F, Renna R, Giordano G, Falcou A, Sili Scavalli A, Petramala L, d'Ettorre G, Galardo G
doi: 10.3390/jcm15010226
RECOMMENDED
Further Publications
Effect of pulmonary rehabilitation for patients with long COVID-19: a systematic review and meta-analysis of randomized controlled trials
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Ther Adv Respir Dis
Li S, Dai B, Hou Y, Zhang L, Liu J, Hou H, Song D, Wang S, Li X, Zhao H, Wang W, Kang J, Tan W
doi: 10.1177/17534666251323482
ARDS
Long-Term Health-Related Quality of Life Following Survival of Acute Respiratory Distress Syndrome and Extracorporeal Membrane Oxygenation Due to COVID-19
J Clin Med
Hermann M, Filipsky R, Bukowski N, Gerger G, Hermann A, Krenn K, Teufel A, Kimberger O, Laxar D, Maleczek M, Schaden E, Wiegele M, Willschke H, Tiboldi A
doi: 10.3390/jcm14103358
COMMENTED
Interstitial Lung Disease
Inhalational exposures associated with risk of interstitial lung disease: a systematic review and meta-analysis
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Thorax
Lee CT, Gandhi SA, Elmrayed S, Barnes H, Lorenzetti D, Salisbury ML, Stewart ID, Barber C, Peters CE, Feary J, Johannson KA
doi: 10.1136/thorax-2024-222306
AsthmaRespiratory Tract Infection
Effect of COVID-19 Disease on Serum Vitamin D Status in Children with Asthma-A Retrospective Study
J Clin Med
Abdul-Razzak J, Ionescu M, Diaconu R, Popescu AD, Niculescu EC, Petrescu IO, Singer CE, Radu L, Anghelina L, Gheonea C
doi: 10.3390/jcm14134525
Lung Cancer
Brief Report: Safety of Pulse-Dose Osimertinib for Treatment of Leptomeningeal Disease or Refractory Brain Metastases in EGFR-Mutated Nonsmall Cell Lung Cancer
Clin Lung Cancer
Sun F, Nagpal S, Singhal S, Neal JW, Wakelee HA, Myall NJ, Bolan P, Riess JW, Gandara DR, Das MS
doi: 10.1016/j.cllc.2025.08.002